The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation and implementation of a mobile app decision support system for quality assurance of tumor boards: Analyzing the concordance rates for testis cancer at a multidisciplinary tumor board of a tertiary referral center.
 
Yasemin Ural
No Relationships to Disclose
 
Axel Heidenreich
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Ipsen; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Ipsen; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma; Bayer; Sanofi
 
Thomas Elter
Stock and Other Ownership Interests - Easy Medical Applications GmbH
Honoraria - Easy Medical Applications GmbH
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Helixor; Incyte; MSD Oncology; SERVIER; Takeda
Patents, Royalties, Other Intellectual Property - Developer of EasyOncology Application; The smartphone application "EasyOncology" has been developed by oncologists of different cancer centers over the past 7 years to understand and support oncological decision making. This APP was validated by retrospective comparison with tumor board decisi
(OPTIONAL) Uncompensated Relationships - Easy Medical Applications GmbH
 
Yasemin Yilmaz
No Relationships to Disclose
 
David A. Pfister
Honoraria - Astellas Oncology; Ipsen; Janssen; Sanofi
Speakers' Bureau - Astellas Oncology; Ipsen; Janssen; Sanofi